Home / ASTRAZEN.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does ASTRAZEN.NS make money? Does ASTRAZEN.NS have pricing power? What's the Earnings Whisper? Will ASTRAZEN.NS profit more as the business scales? What is ASTRAZEN.NS's management track record? Is ASTRAZEN.NS's current price justified?

AstraZeneca Pharma India Limited

₹5970.5 -$2807.00 (-31.98%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹5937

Day Range

₹5843.5₹6009

Year Range

₹5640₹9849.5

Market Cap

149.26B

AVG Volume

10.91K

Trailing/Forward PE

88/179.08

PEG ratio

-11.76

Dividend Yield

0.60%

Next Earnings Date

Primary Exchange

National Stock Exchange of India

Revenue (INR) · A

ASTRAZEN.NS Revenue (INR) by year
Period	Revenue (INR)
2026	22.76B
2025	17.13B
2024	12.96B
2023	10.03B
2022	8.06B
2021	8.09B
2020	8.32B
2019	7.28B
2018	5.71B
2017	5.52B

Net Income (INR) · A

ASTRAZEN.NS Net Income (INR) by year
Period	Net Income (INR)
2026	1.88B
2025	1.16B
2024	1.62B
2023	992.9M
2022	616M
2021	933M
2020	722.1M
2019	544.5M
2018	260.46M
2017	267.39M

Operating Income (INR) · A

ASTRAZEN.NS Operating Income (INR) by year
Period	Operating Income (INR)
2026	2.33B
2025	2.15B
2024	1.22B
2023	1.49B
2022	696.5M
2021	1.16B
2020	1.03B
2019	563.82M
2018	341.3M
2017	297.73M

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (INR) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

AstraZeneca Pharma India Limited

Video analysis: ASTRAZEN.NS

News: ASTRAZEN.NS

Similar companies